Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maple Grain and Oil Industry (Heilongjiang) Co., Ltd. is a specialized manufacturer of soybean-derived products for the pharmaceutical, nutraceutical, and food sectors. Based in China's Heilongjiang province, the company focuses on the production of high-purity pharmaceutical-grade soybean oil and lecithin. These products serve as critical excipients in the formulation of intravenous drug delivery systems, such as lipid emulsions and parenteral nutrition. The company operates as a key subsidiary of the Maple Leaf Group (Fengye Group) and maintains large-scale, GMP-compliant processing facilities. Its manufacturing processes utilize advanced extraction and refining technologies to meet international pharmacopeia standards. By providing high-quality raw materials, Maple Grain and Oil Industry supports the global pharmaceutical supply chain and drug development efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maple Grain and Oil Industry.